BECTON DICKINSON GESELLSCHAFT MIT BESCHRÄNKTER HAFTUNG

Becton Dickinson Gesellschaft mit beschränkter Haftung specializes in the manufacturing of in-vitro diagnostic substances, with a focus on microbiology culture media and reagents used in clinical and military healthcare settings. Their technical expertise lies in the development, production, and reliable delivery of sterile, quality-controlled diagnostic formulations designed for pathogen detection and microbial identification. The company demonstrates precision in meeting stringent regulatory requirements for medical diagnostics, ensuring batch consistency, shelf stability, and compatibility with automated laboratory systems. Their specialization in microbiological culture media suggests deep competency in nutrient formulation, pH optimization, and contamination control—critical for accurate diagnostic outcomes in field and hospital environments. The contractor has delivered diagnostic products to the Department of Defense, specifically supporting the Landstuhl Regional Medical Center in Germany, indicating direct engagement with military medical logistics and expeditionary healthcare operations. This relationship underscores their ability to supply mission-critical diagnostic reagents under demanding operational conditions, likely adhering to military specifications for packaging, cold chain integrity, and rapid deployment. Their primary industry focus is on NAICS 325413, which encompasses the manufacturing of diagnostic reagents and substances used in clinical laboratories. This positions them within the specialized niche of infectious disease diagnostics, serving high-acuity environments where rapid and accurate microbial identification is essential. They are not a broad-spectrum medical device manufacturer but a focused supplier of consumable diagnostic substances critical for microbiology workflows. The entity is structured as a limited liability company (2L) headquartered in Heidelberg, Germany, with no publicly listed government certifications. Their geographic presence is centered in Europe, with demonstrated capability to support U.S. government medical facilities overseas. They operate as a niche supplier in the global defense and clinical diagnostics supply chain, valued for technical reliability rather than scale or diversified product portfolios.